Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 2/2015

Open Access 01-12-2015 | Poster presentation

Analysis of repeated measures of multiple surgical sites within a factorial randomised controlled trial

Authors: Gemma Clayton, Katie Pike, Gianni D Angelini, Chris A Rogers

Published in: Trials | Special Issue 2/2015

Login to get access

Excerpt

In heart bypass surgery, pieces of artery or vein (“conduits”) taken from elsewhere in the patients’ body are used to bypass the blocked or narrowed coronary arteries and improve the blood supply to the heart. The “Hyperplasia and Atherogenesis in Bypass Vein Grafts Following Different Surgical Preparation Techniques” (HArVeST) trial, is a single-centre study investigating if new methods of taking and preparing the conduit can improve the outcome for patients. …
Metadata
Title
Analysis of repeated measures of multiple surgical sites within a factorial randomised controlled trial
Authors
Gemma Clayton
Katie Pike
Gianni D Angelini
Chris A Rogers
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Trials / Issue Special Issue 2/2015
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/1745-6215-16-S2-P126

Other articles of this Special Issue 2/2015

Trials 2/2015 Go to the issue

Oral presentation

Realising the potential of patient and public involvement to make a difference: what can trial teams do?

Oral presentation

A framework for the design and analysis of phase III randomised trials in uncommon diseases

Poster presentation

Validation of the Vitiligo noticeability scale: a patient-reported outcome measure of Vitiligo treatment success

Oral presentation

Complier-average causal effects for multivariate outcomes: an instrumental variable approach with application to health economics

Poster presentation

Clinical trial data visualisation

Poster presentation

Reviewing the evidence supporting predictive biomarkers in European medicines agency indications and contraindications using visual plots